Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.

Saved in:
Bibliographic Details
Title: Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
Authors: Cappellari M; SSO Stroke Unit, U.O. Neurologia d.O., DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata, Piazzale A. Stefani 1, 37126, Verona, Italy, manuel_cappellari@libero.it., Moretto G, Micheletti N, Donato F, Tomelleri G, Gulli G, Carletti M, Squintani GM, Zanoni T, Ottaviani S, Romito S, Tommasi G, Musso AM, Deotto L, Gambina G, Zimatore DS, Bovi P
Source: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2014 May; Vol. 37 (4), pp. 549-56.
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print Cited Medium: Internet ISSN: 1573-742X (Electronic) Linking ISSN: 09295305 NLM ISO Abbreviation: J Thromb Thrombolysis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-742X
DOI:10.1007/s11239-013-0980-2